Synthetic small RNAs: Current status, challenges, and opportunities

Area of Science:

• Synthetic Biology
• Molecular Biology
• RNA Therapeutics

Background:

• Small regulatory RNAs (sRNAs) are key regulators of gene expression at transcriptional, post-transcriptional, and translational levels.
• These molecules interact with protein and messenger RNA targets, influencing biological processes.
• The development of engineered RNA molecules, such as riboregulators and riboswitches, has expanded the toolkit for precise genetic control.

Purpose of the Study:

• To review recent advances in RNA synthetic biology, focusing on riboregulators and riboswitches.
• To highlight the design, characterization, and implementation of these RNA tools across various organisms.
• To explore the future potential of RNA-based technologies in metabolic engineering, genetic control, and broader applications.

Main Methods:

• Discussion of the development and engineering principles of riboregulators and riboswitches.
• Review of studies demonstrating the application of these RNA molecules in diverse biological systems (bacteria, yeast, mammalian cells).
• Analysis of recent literature on RNA synthetic biology advancements.

Main Results:

• Riboregulators and riboswitches are self-assembling RNA molecules capable of dynamic conformational changes, functioning as regulatory switches.
• These engineered RNAs have been successfully designed, characterized, and implemented in a wide range of organisms and cell types.
• Significant progress has been made in harnessing RNA molecules for sophisticated genetic control and metabolic engineering.

Conclusions:

• RNA synthetic biology, particularly through riboregulators and riboswitches, offers powerful tools for precise biological control.
• The versatility of these RNA elements supports their expansion into novel biotechnological, biomedical, and industrial applications.
• Continued research promises to enhance the capabilities and applications of engineered RNA molecules.